跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
盧 孟良
教授
,
精神學科
合聘教授
,
臨床醫學研究所
合聘教授
,
心智意識與腦科學研究博士學位學程
主治醫師
,
臺北市立萬芳醫院
成員
,
臺北醫學大學神經醫學研究中心
成員
,
臺北神經醫學中心
https://orcid.org/0000-0003-3184-6554
電子郵件
mongliang
tmu.edu
tw
h-index
3430
引文
32
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1997 …
2025
每年研究成果
概覽
指紋
網路
專案
(21)
研究成果
(168)
資料集
(17)
類似的個人檔案
(7)
指紋
查看啟用 Mong-Liang Lu 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Neuroscience
Dementia Praecox
100%
Olanzapine
38%
Typical Antipsychotic
27%
Clozapine
26%
Antipsychotic
24%
Major Depressive Disorder
23%
Antidepressant
21%
Bipolar Disorder
21%
Placebo
16%
Meta-Analysis
16%
Oxytocin
14%
Depression
13%
Metformin
11%
Pediatric Trauma
10%
Adiponectin
9%
Fatty Acids
9%
Cognitive Function
9%
Late Life Depression
8%
Orexin-A
8%
DNA Polymorphism
8%
Metabolic Pathway
7%
Negative Syndrome
6%
Polyunsaturated Fatty Acid
6%
Erythrocyte Membrane
6%
Omega 3 Fatty Acid
6%
Docosahexaenoic Acid
6%
Fluvoxamine
6%
MicroRNA
6%
Positive Syndrome
6%
Genetic Polymorphism
5%
Mental Disorder
5%
Schizoaffective Disorder
5%
Cognitive Disorders
5%
Escitalopram
5%
Receptor Gene
5%
Randomized Controlled Trial
5%
Behavior (Neuroscience)
5%
Ghrelin
5%
Prolactin
5%
Body Mass Index
5%
Pharmacology, Toxicology and Pharmaceutical Science
Olanzapine
40%
Antipsychotic
35%
Typical Antipsychotic
32%
Clozapine
29%
Antidepressant
26%
Cohort Study
24%
Metabolic Syndrome X
21%
Disease
15%
Major Depression
14%
Metabolic Disorder
13%
Fluvoxamine
11%
Symptom
11%
Attention Deficit Disorder
10%
Selective Serotonin Reuptake Inhibitor
10%
Risperidone
8%
Metformin
8%
Pharmacokinetics
8%
Liver Cell Carcinoma
8%
Placebo-Controlled Study
8%
Ghrelin
8%
Orexin A
8%
Adiponectin
8%
Adverse Event
8%
Monotherapy
7%
Negative Syndrome
7%
Asthma
7%
Quetiapine
7%
Pharmacotherapy
6%
Hyperprolactinemia
6%
Bipolar Disorder
6%
Cross-Sectional Study
5%
Case-Control Study
5%
Randomized Controlled Trial
5%
Schizoaffective Psychosis
5%
Triacylglycerol
5%
Methylphenidate
5%
Chemotherapy
5%
Stomach Cancer
5%
Omega-3 Fatty Acid
5%
Toxic Injury
5%
Hepatitis C
5%
Interferon
5%
Prolactin
5%
Medicine and Dentistry
Antidepressant
23%
Cohort Analysis
18%
Major Depressive Episode
14%
Symptom
12%
Disease
11%
Drug Therapy
11%
Typical Antipsychotic
10%
Hazard Ratio
9%
Clozapine
8%
Meta-Analysis
8%
Attention Deficit Disorder
8%
Outpatient
7%
Gut Microbiota
7%
Cognition
7%
Asthma
7%
Risperidone
6%
Selective Serotonin Reuptake Inhibitor
6%
Diabetes Mellitus
6%
Olanzapine
5%
Depression
5%
Hepatocellular Carcinoma
5%
Late Life Depression
5%
Case-Control Study
5%
Speech and Language Impairment
5%
Stomach Cancer
5%
Water-Electrolyte Imbalance
5%
Adverse Event
5%
